8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 2, 2008

BSD MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	0-10783	75-1590407
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification)

2188 West 2200 South

Salt Lake City, Utah 84119

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code:  (801) 972-5555

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

BSD Medical Corporation issued a press release on May 2, 2008.  A copy of the press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release of BSD Medical Corporation dated May 2, 2008

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  May 2, 2008
	By:	/s/  Hyrum A. Mead
		Hyrum A. Mead President

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press Release of BSD Medical Corporation dated May 2, 2008

EX-99.1

Exhibit 99.1

For Immediate Release

BSD Medical to Present Its Cancer Therapy Systems at the 2008 World Congress of Brachytherapy

SALT LAKE CITY, Utah May 2, 2008—BSD Medical Corporation (NASDAQ:BSDM) announced today that the company will present its systems for cancer therapy at the 2008 World Congress of Brachytherapy (the annual meeting of the American Brachytherapy Society or ABS) from May 4-6 2008 in Boston, Massachusetts.  The company’s objective at ABS is to leverage the growing clinical interest in the use of hyperthermia therapy with brachytherapy.

The ABS organization consists of BSD Medical’s primary customers, including oncologists, physicists and other health care providers practicing brachytherapy.  A wide variety of national and international speakers have been invited to present data at the meeting. Founded in 1978, the American Brachytherapy Society is a nonprofit organization that seeks to provide insight and research into the use of brachytherapy in malignant and benign conditions.

Clinical studies have shown hyperthermia to be a safe and well tolerated therapy when combined with brachytherapy for the treatment of certain types of locally advanced cancer.  Brachytherapy is a form of radiation therapy where radioactive sources are placed inside or next to the area requiring treatment.  BSD Medical systems deliver hyperthermia for use in combination with brachytherapy through small, interstitial microwave antennae that are inserted through the same catheters used to place the radioactive sources.

Because it is less invasive than surgery and less disruptive to the patient, brachytherapy offers appropriate patients an effective alternative cancer treatment.  Brachytherapy is used with hyperthermia to treat advanced localized prostate cancer, breast cancer, cervical cancer and cancers of the head and neck.

About BSD Medical Corporation

BSD Medical is a leading developer of systems used to provide cancer therapies requiring precision-focused heat through RF/microwave technologies. The company’s systems have been designed to kill cancer through heat alone, or as companion therapies to improve the combined results when used along with radiation treatments.  For further information visit BSD Medical's website at www.BSDMedical.com.

#####

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission.